X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2880) 2880
Publication (273) 273
Newsletter (85) 85
Newspaper Article (23) 23
Book Review (19) 19
Book Chapter (8) 8
Magazine Article (8) 8
Dissertation (5) 5
Web Resource (4) 4
Trade Publication Article (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tazobactam (1648) 1648
humans (1219) 1219
index medicus (953) 953
piperacillin-tazobactam (791) 791
microbiology (786) 786
pharmacology & pharmacy (757) 757
infectious diseases (744) 744
penicillanic acid - analogs & derivatives (701) 701
piperacillin (670) 670
antibiotics (628) 628
male (572) 572
female (539) 539
anti-bacterial agents - therapeutic use (453) 453
microbial sensitivity tests (450) 450
middle aged (408) 408
anti-bacterial agents - pharmacology (376) 376
infections (358) 358
aged (351) 351
adult (338) 338
penicillanic acid - pharmacology (322) 322
piperacillin/tazobactam (309) 309
beta-lactamase inhibitors (305) 305
bacteria (275) 275
penicillanic acid - therapeutic use (272) 272
drug resistance (263) 263
health aspects (262) 262
anti-bacterial agents - administration & dosage (254) 254
piperacillin - therapeutic use (252) 252
resistance (252) 252
pharmacokinetics (250) 250
meropenem (247) 247
cefepime (244) 244
pseudomonas aeruginosa (241) 241
piperacillin - pharmacology (239) 239
ceftazidime (238) 238
research (237) 237
escherichia-coli (234) 234
mortality (228) 228
antimicrobial agents (225) 225
hospitals (221) 221
sulbactam (218) 218
enterobacteriaceae (209) 209
vancomycin (209) 209
patients (208) 208
infection (206) 206
pseudomonas-aeruginosa (206) 206
treatment outcome (205) 205
analysis (197) 197
pneumonia (197) 197
therapy (197) 197
risk factors (190) 190
imipenem (189) 189
clavulanic acid (184) 184
penicillanic acid - administration & dosage (181) 181
piperacillin - administration & dosage (181) 181
polycyclic compounds (179) 179
bacteremia (170) 170
drug resistance in microorganisms (169) 169
pseudomonas aeruginosa - drug effects (169) 169
care and treatment (168) 168
epidemiology (166) 166
adolescent (163) 163
dosage and administration (159) 159
biochemical phenomena, metabolism, and nutrition (157) 157
immunology (157) 157
cephalosporins (156) 156
retrospective studies (155) 155
pharmacodynamics (153) 153
drug therapy (152) 152
anti-bacterial agents - pharmacokinetics (150) 150
bacterial infections and mycoses (148) 148
aged, 80 and over (146) 146
medical research (145) 145
ciprofloxacin (142) 142
carbapenems (140) 140
prospective studies (139) 139
beta lactamases (136) 136
gram-negative bacteria (136) 136
susceptibility (136) 136
internal medicine (133) 133
sepsis (133) 133
amikacin (132) 132
bacterial infections - drug therapy (132) 132
drug therapy, combination (131) 131
anti-bacterial agents - adverse effects (130) 130
klebsiella-pneumoniae (129) 129
pediatrics (129) 129
animals (128) 128
escherichia coli - drug effects (125) 125
pathogens (125) 125
piperacillin - pharmacokinetics (125) 125
diagnosis (124) 124
medicine, experimental (124) 124
penicillanic acid - adverse effects (124) 124
penicillanic acid - pharmacokinetics (123) 123
antimicrobial resistance (120) 120
piperacillin - adverse effects (120) 120
risk-factors (120) 120
beta-lactamases - metabolism (117) 117
e coli (117) 117
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2819) 2819
French (43) 43
Spanish (43) 43
German (36) 36
Chinese (22) 22
Japanese (20) 20
Italian (9) 9
Turkish (7) 7
Portuguese (5) 5
Korean (3) 3
Czech (2) 2
Hungarian (2) 2
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S56
Le controle de la resistance aux antibiotiques (ATB) passe par une maitrise de la consommation des ATB (CAB). La surveillance en reseau des CAB dans les... 
Tazobactam
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 03/2019, Volume 25, Issue 3, pp. 182 - 191
Journal Article
JAMA Pediatrics, ISSN 2168-6203, 05/2018, Volume 172, Issue 5, p. 494
Journal Article
JAMA Pediatrics, ISSN 2168-6203, 05/2018, Volume 172, Issue 5, p. 494
Journal Article
Critical care medicine, 07/2018, Volume 46, Issue 7, p. e725
Journal Article
Transfusion Medicine, ISSN 0958-7578, 04/2019, Volume 29, Issue 2, pp. 138 - 140
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Original Investigation | Research
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A119
Nous rapportons le cas d'une entite clinique de description recente pouvant A*tre confondue avec une uveite anterieure aigue : le syndrome de transillumination... 
Corticosteroids | Tazobactam | Prednisone
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A210
La fievre prolongee d'origine indeterminee est un defi diagnostique en medecine interne. En cas de paraplegie avec anesthesie associee, la pauvrete des signes... 
Tazobactam | Anticoagulants (Medicine) | Colchicine
Journal Article
Revista Iberoamericana de Micología, ISSN 1130-1406, 2018, Volume 36, Issue 1, pp. 51 - 52
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 03/2017, Volume 61, Issue 3
Infections caused by multidrug-resistant Pseudomonas aeruginosa (MDRPA) present a major problem for therapeutic management. We report here our experience with... 
URINARY-TRACT-INFECTIONS | CEFTOLOZANE/TAZOBACTAM | ceftolozane-tazobactam | DOUBLE-BLIND | Pseudomonas aeruginosa | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | salvage therapy | COMBINATION
Journal Article
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S24
En cas d'aplasie febrile, le maintien d'une antibiotherapie a large spectre jusqu'a la sortie d'aplasie etait jusqu'a recemment recommande. L'ECIL4 (European... 
Tazobactam | Valuation | Leukemia
Journal Article
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S98
Materiels et methodes Les meningites a Klebsiella sp. sont tres peu decrites et pourtant la mortalite est elevee. Elles semblent survenir avant 1 an, ou aux... 
Pneumonia | Tazobactam | Bacterial pneumonia
Journal Article
Critical Care Medicine, ISSN 0090-3493, 07/2018, Volume 46, Issue 7, pp. e725 - e725
Journal Article
Respirology, ISSN 1323-7799, 11/2018, Volume 23, Issue S2, pp. 193 - 193
Journal Article
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 12/2001, Volume 45, Issue 12, pp. 3548 - 3554
There is little information about the clinical effectiveness of cefepime and piperacillin-tazobactam in the treatment of infections caused by extended-spectrum... 
Tazobactam
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.